Spero Therapeutics (NASDAQ:SPRO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Spero Therapeutics (SPRO) operate in?

Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Spero Therapeutics Stock (NASDAQ: SPRO) stock price, news, charts, stock research, profile.

Open	$1.37
Close	$1.33
Volume / Avg.	129.39K / 114.00K
Day Range	$1.32 - $1.37
52 Wk Range	0.99 - 1.89
Market Cap	$71.89M
P/E Ratio	3.99
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	0.92%
Days to Cover	3.04

Recent News

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.

Avi Kapoor

Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) rose sharply in today’s pre-market trading after the company reported February trading metrics.

Avi Kapoor

EXCLUSIVE: Top 10 Stocks Searched On Benzinga Pro In September: Where Do Tesla, Apple, Bed Bath & Beyond Rank?

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.

Chris Katje

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About Spero Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, develo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Spero Therapeutics (SPRO) stock?

You can purchase shares of Spero Therapeutics (NASDAQ:SPRO) through any online brokerage.

View our list of the best stock brokerages

Who are Spero Therapeutics (SPRO) competitors?

Other companies in Spero Therapeutics’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB), Immuneering (NASDAQ:IMRX), Armata Pharmaceuticals (AMEX:ARMP) and Gritstone Bio (NASDAQ:GRTS).

What is the forecast, or price target, for Spero Therapeutics (SPRO) stock?

There is no analysis for Spero Therapeutics to provide a consensus price target.

What is the current price for Spero Therapeutics (SPRO)?

The stock price for Spero Therapeutics (NASDAQ: SPRO) is $1.33 last updated September 20, 2024 at 4:02 PM EDT.

Does Spero Therapeutics (SPRO) pay a dividend?

A quarterly cash dividend of 0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on October 7, 2015 to stockholders of record on September 16, 2015.

When is Spero Therapeutics (NASDAQ:SPRO) reporting earnings?

Spero Therapeutics does not have any upcoming earnings scheduled.

Is Spero Therapeutics (SPRO) going to split?

There is no upcoming split for Spero Therapeutics.

What sector and industry does Spero Therapeutics (SPRO) operate in?

Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now